EyePoint Pharmaceuticals Reports Positive Results from GLP Toxicology Study of EYP-1901, a Potential Six-month Treatment of Wet Age-related Macular DegenerationGlobeNewsWire • 12/03/20
EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4GlobeNewsWire • 11/19/20
EyePoint Pharmaceuticals Announces Presentations at the Upcoming American Academy of Ophthalmology 2020 Virtual Annual MeetingGlobeNewsWire • 11/10/20
EyePoint Pharmaceuticals, Inc.'s (EYPT) CEO Nancy Lurker on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/05/20
EyePoint Pharmaceuticals (EYPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/29/20
EyePoint Pharmaceuticals Announces Third Quarter 2020 Financial Results Release Date and Conference Call InformationGlobeNewsWire • 10/29/20
EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility Modifying 2020 and 2021 Revenue CovenantsGlobeNewsWire • 10/08/20
EyePoint Pharmaceuticals Announces Preliminary Net Product Revenue for Third Quarter 2020GlobeNewsWire • 10/07/20
EyePoint Pharmaceuticals Secures New Purchase and Marketing Agreement with Vantage Outsourcing for DEXYCU®GlobeNewsWire • 08/24/20
EyePoint Pharmaceuticals Receives $9.5 Million in Upfront Cash from Ocumension Therapeutics Under Expanded License AgreementsGlobeNewsWire • 08/20/20
EyePoint Pharmaceuticals, Inc.'s (EYPT) CEO Nancy Lurker on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 08/05/20
EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce U.S. Commercial Alliance for DEXYCU®GlobeNewsWire • 08/04/20
EyePoint Pharmaceuticals Announces Second Quarter 2020 Financial Results Release Date and Conference Call InformationGlobeNewsWire • 07/29/20
EyePoint Pharmaceuticals Presents Data Supporting YUTIQ® at the American Society of Retina Specialists (ASRS) Virtual Annual MeetingGlobeNewsWire • 07/27/20
EyePoint Pharmaceuticals Expands Executive Leadership Team with the Appointment of Jay S. Duker, M.D.GlobeNewsWire • 07/13/20